{"schema_version":"1.0","type":"article","title":"偏頭痛總挑月經前後來？7天預防研究，能少痛多少？","url":"https://drugnews.com.tw/articles/2026-10-04-luna-atogepant-menstrual-migraine-2026.html","markdown_url":"https://drugnews.com.tw/articles/2026-10-04-luna-atogepant-menstrual-migraine-2026.md","lang":"zh-Hant","date":"2026-10-04","publish_at":"2026-10-04T08:00:00+08:00","updated_at":"2026-10-04","category":"商業分析系列","topic":"商業分析系列","tags":["LUNA","atogepant","AbbVie","CGRP","偏頭痛"],"summary":"月經前後已經不好受，再碰上偏頭痛、怕光或噁心，工作、接送與原本排好的行程都可能被打亂。對發作時間反覆落在這個窗口的人，問題很直接：能不能在頭痛來之前，先降低那幾天的負擔？","key_points":[],"facts":[],"sections":[],"references":[{"title":"AbbVie：LUNA第三期初步主要結果（2026-09-10","source":"","date":"","url":""},{"title":"https://news.abbvie.com/2026-09-10-AbbVie-Extends-Migraine-Leadership-with-Positive-Phase-3-Atogepant-Results-in-Menstrual-Migraine","source":"","date":"","url":"https://news.abbvie.com/2026-09-10-AbbVie-Extends-Migraine-Leadership-with-Positive-Phase-3-Atogepant-Results-in-Menstrual-Migraine"},{"title":"QULIPTA美國處方資訊（Revised 2025-09","source":"","date":"","url":""},{"title":"https://www.rxabbvie.com/pdf/qulipta_pi.pdf","source":"","date":"","url":"https://www.rxabbvie.com/pdf/qulipta_pi.pdf"},{"title":"ClinicalTrials.gov：NCT06806293（研究登錄入口","source":"","date":"","url":""},{"title":"https://clinicaltrials.gov/study/NCT06806293","source":"","date":"","url":"https://clinicaltrials.gov/study/NCT06806293"},{"title":"日本jRCT：jRCT2051240268（研究登錄入口","source":"","date":"","url":""},{"title":"https://jrct.mhlw.go.jp/latest-detail/jRCT2051240268","source":"","date":"","url":"https://jrct.mhlw.go.jp/latest-detail/jRCT2051240268"},{"title":"日本厚生勞動省：LUNA公開試驗資訊（頁面最後更新2026-09-27；本輪查閱2026-09-28","source":"","date":"","url":""},{"title":"https://rctportal.mhlw.go.jp/s/detail/um?trial_id=jRCT2051240268","source":"","date":"","url":"https://rctportal.mhlw.go.jp/s/detail/um?trial_id=jRCT2051240268"},{"title":"Charité研究團隊：月經與CGRP研究說明（2023-02-23","source":"","date":"","url":""},{"title":"https://mentalhealth.charite.de/en/metas/en_meldung/artikel/detail/why_migraine_frequently_occurs_during_menstruation/","source":"","date":"","url":"https://mentalhealth.charite.de/en/metas/en_meldung/artikel/detail/why_migraine_frequently_occurs_during_menstruation/"},{"title":"Frovatriptan月經相關偏頭痛間歇預防隨機研究（2004-07-27","source":"","date":"","url":""},{"title":"https://pubmed.ncbi.nlm.nih.gov/15277618/","source":"","date":"","url":"https://pubmed.ncbi.nlm.nih.gov/15277618/"},{"title":"AbbVie：M24-859官方試驗頁（頁面未標發布日；查閱2026-09-27","source":"","date":"","url":""},{"title":"https://www.abbvieclinicaltrials.com/study/M24-859","source":"","date":"","url":"https://www.abbvieclinicaltrials.com/study/M24-859"}],"images":[{"alt":"女性與行事曆標示月經周邊風險窗口，七天短程預防的研究安排連到偏頭痛日誌與日常功能評估。","url":"https://drugnews.com.tw/assets/articles/luna-atogepant-menstrual-migraine-2026/FIG01_ZH_R2.png"},{"alt":"上方為atogepant阻斷CGRP受體的功能示意；下方將依預估月經安排的七天給藥與依月經開始界定的PMP評估分開列出，兩者不共用比例時間軸。","url":"https://drugnews.com.tw/assets/articles/luna-atogepant-menstrual-migraine-2026/FIG02_ZH_R6.png"},{"alt":"三個週期的圍月經期（PMP）連到偏頭痛日數平均變化；atogepant與安慰劑分別顯示減少1.20與0.40天，另列組間差0.80天及P<0.0001。","url":"https://drugnews.com.tw/assets/articles/luna-atogepant-menstrual-migraine-2026/FIG03_ZH_R3.png"},{"alt":"中央女性手持筆，面前是標示「我的日記」的日誌；周圍四框以連線與中央相接。左上「功能影響」配電腦與居家圖示，文字說明公司已報告功能相關次要終點達標、完整效應量待公開；右上「急性藥物使用」配用藥紀錄；左下「不良事件與耐受性」配不良事件紀錄及警示符號；右下「持續使用」配行事曆，說明跨週期使用情況。","url":"https://drugnews.com.tw/assets/articles/luna-atogepant-menstrual-migraine-2026/FIG04_ZH_R3.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/luna-atogepant-menstrual-migraine-2026/FIG01_ZH_R2.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-10-04）。偏頭痛總挑月經前後來？7天預防研究，能少痛多少？。https://drugnews.com.tw/articles/2026-10-04-luna-atogepant-menstrual-migraine-2026.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-10-04-luna-atogepant-menstrual-migraine-2026-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}